Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LVGN7409 |
Trade Name | |
Synonyms | LVGN-7409|LVGN 7409 |
Drug Descriptions |
LVGN7409 is an agonist antibody targeting CD40, which may lead to activation of downstream signaling and T-cell activity (NCI Drug Dictionary). |
DrugClasses | CD40 Antibody 14 |
CAS Registry Number | NA |
NCIT ID | C178278 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + Cyclophosphamide + LVGN3616 + LVGN6051 + LVGN7409 | Bevacizumab Cyclophosphamide LVGN3616 LVGN6051 LVGN7409 | 0 | 1 |
LVGN3616 + LVGN6051 + LVGN7409 + Nab-paclitaxel | LVGN3616 LVGN6051 LVGN7409 Nab-paclitaxel | 0 | 1 |
LVGN3616 + LVGN7409 | LVGN3616 LVGN7409 | 0 | 1 |
LVGN7409 | LVGN7409 | 0 | 1 |